Cargando…

Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid X Receptor

BACKGROUND: Qingre Lidan tablets (QLTs) are a compound preparation of Chinese medicine that have long been used clinically to treat poor bile circulation caused by the inflammation and obstruction of the gallbladder and bile duct and to relieve jaundice and other symptoms. However, its material basi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yafei, Yan, Shixin, Chang, Yang, Yin, Jiaoyang, Li, Hongyu, Yan, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729052/ https://www.ncbi.nlm.nih.gov/pubmed/36506808 http://dx.doi.org/10.1155/2022/1589388

Ejemplares similares

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
por: Wu, Peijie, et al.
Publicado: (2021)

Promoter DNA Methylation of Farnesoid X Receptor and Pregnane X Receptor Modulates the Intrahepatic Cholestasis of Pregnancy Phenotype
por: Cabrerizo, Romina, et al.
Publicado: (2014)

Systematically Characterizing Chemical Profile and Potential Mechanisms of Qingre Lidan Decoction Acting on Cholelithiasis by Integrating UHPLC-QTOF-MS and Network Target Analysis
por: Huang, Peng, et al.
Publicado: (2019)

Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit Farnesoid X Receptor Resulting in a Cholestatic Phenotype
por: Abu-Hayyeh, Shadi, et al.
Publicado: (2013)

Progressive familial intrahepatic cholestasis — farnesoid X receptor deficiency due to NR1H4 mutation: A case report
por: Czubkowski, Piotr, et al.
Publicado: (2021)

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
por: Petrescu, Anca D., et al.
Publicado: (2021)

Intrahepatic cholestasis of pregnancy or azithromycin-induced intrahepatic cholestasis: A case report
por: Han, Baoshi, et al.
Publicado: (2017)

Quality Evaluation of Traditional Chinese Medicine Compounds in Xiaoyan Lidan Tablets: Fingerprint and Quantitative Analysis Using UPLC-MS
por: Yang, Na, et al.
Publicado: (2016)

Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
por: Wang, Rulin, et al.
Publicado: (2022)

Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2
por: Arthur Lorio, Eric, et al.
Publicado: (2020)

Intrahepatic cholestasis of pregnancy
por: Pusl, Thomas, et al.
Publicado: (2007)

Intrahepatic Cholestasis of Pregnancy
por: Jurk, Stanisław M., et al.
Publicado: (2021)

Intrahepatic cholestasis of pregnancy
por: Hobson, Sebastian, et al.
Publicado: (2022)

Molecular Pathogenesis of Intrahepatic Cholestasis of Pregnancy
por: Xiao, Jianping, et al.
Publicado: (2021)

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis
por: Schramm, Christoph, et al.
Publicado: (2022)

Association Between Complete Blood Count Components and Intrahepatic Cholestasis of Pregnancy
por: Silva, Jessica, et al.
Publicado: (2020)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Familial Intrahepatic Cholestasis: An Update
por: Riely, Caroline A.
Publicado: (1979)

Progressive familial intrahepatic cholestasis
por: Davit-Spraul, Anne, et al.
Publicado: (2009)

Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig model
por: WU, XIAO, et al.
Publicado: (2016)

Intrahepatic Cholestasis in Pregnancy: Review of the Literature
por: Piechota, Joanna, et al.
Publicado: (2020)

Bile Acids in Intrahepatic Cholestasis of Pregnancy
por: Majsterek, Maciej, et al.
Publicado: (2022)

Prolonged and Recurrent Intrahepatic Cholestasis of Pregnancy
por: Kaviani, Rojin, et al.
Publicado: (2023)

Bacterial metabolites directly modulate farnesoid X receptor activity
por: Zhang, Xianqin, et al.
Publicado: (2015)

Rational use of drugs to alleviate adverse outcomes caused by COVID-19 quarantine in women with intrahepatic cholestasis of pregnancy
por: Cai, Qin-Yu, et al.
Publicado: (2023)

Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis
por: Vitale, Giovanni, et al.
Publicado: (2023)

Hereditary spherocytosis complicated by intrahepatic cholestasis: two case reports
por: Han, Ning, et al.
Publicado: (2022)

Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
por: Xiang, Dong, et al.
Publicado: (2019)

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
por: Trauner, Michael, et al.
Publicado: (2019)

In Search of an Accurate Evaluation of Intrahepatic Cholestasis of Pregnancy
por: Martinefski, Manuela, et al.
Publicado: (2012)

Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
por: Liu, Ying, et al.
Publicado: (2018)

Expanding etiology of progressive familial intrahepatic cholestasis
por: Henkel, Sarah AF, et al.
Publicado: (2019)

Molecular overview of progressive familial intrahepatic cholestasis
por: Amirneni, Sriram, et al.
Publicado: (2020)

Intrahepatic Cholestasis of Pregnancy: An Autobiographical Case Report
por: Bartolone, Samantha, et al.
Publicado: (2022)

Newer variants of progressive familial intrahepatic cholestasis
por: Vinayagamoorthy, Vignesh, et al.
Publicado: (2021)

Effects of Intrahepatic Cholestasis on the Foetus During Pregnancy
por: Sahni, Anushree, et al.
Publicado: (2022)

Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy
por: Granese, Roberta, et al.
Publicado: (2023)

Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma
por: Chen, Cuilan, et al.
Publicado: (2022)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4
por: Si, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_49ibocnf09cr5sm6532nkflhbt